Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Treatment of Facial Shingles

Antiviral Therapy Recommendations

  • The American Academy of Dermatology recommends valacyclovir 1 gram orally three times daily for 7 days as the first-line treatment for facial herpes zoster due to its superior bioavailability and convenient dosing schedule compared to acyclovir 1, 2
  • Treatment should be initiated as soon as possible, ideally within 72 hours of rash onset, although benefits may still be observed with later initiation 1
  • Alternative options include acyclovir 800 mg orally five times daily for 7 days, but this regimen requires more frequent dosing which may reduce compliance in elderly patients 1, 3

Role of Corticosteroids

  • The American Academy of Dermatology suggests that prednisone can be beneficial in reducing acute pain and inflammation when used alongside antivirals 2
  • Prednisone may be used as an adjunctive therapy to antivirals in select cases of severe facial shingles to reduce inflammation and pain 2
  • However, corticosteroids should be used with caution in elderly patients due to potential adverse effects including increased risk of infection, hypertension, and hyperglycemia 2

Special Considerations for Facial Involvement

  • Facial zoster requires particular attention due to the risk of complications, including potential involvement of cranial nerves 2
  • Monitor closely for ocular involvement, which may require additional treatment and specialist referral 4
  • For severe cases or if there are signs of dissemination, consider switching to intravenous acyclovir until clinical improvement occurs 1, 2

Treatment Duration and Follow-up

  • Continue treatment for the full 7-day course even if symptoms begin to improve 1
  • Treatment may need to be extended if new lesions continue to form or healing is incomplete after the initial course 1, 3
  • Schedule follow-up within 1 week to assess treatment response, particularly to monitor for potential complications such as postherpetic neuralgia 4

Common Pitfalls to Avoid

  • Inadequate dosing or premature discontinuation of antiviral therapy may lead to treatment failure and increased risk of complications 3
  • Topical antiviral therapy is substantially less effective than systemic therapy and is not recommended 2
  • Failing to recognize potential ocular involvement in facial shingles, which may require additional treatment and specialist referral 4

Efficacy and Safety in Elderly Patients

  • For patients with renal impairment, which is common in elderly individuals, dose adjustment of valacyclovir may be necessary 1

REFERENCES

1

Treatment of Herpes Zoster [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Herpes Zoster [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Shingles with Antiviral Therapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025